GlassScriptPhysician profile
Marie Carmelle Liburd
NPI 1013012541
$351.04
in general payments reported to CMS, 2019-2025
10 companies · $75.90 in 2025
The $75.90 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.56 · 2020: $38.15 · 2021: $35.46 · 2022: $71.33 · 2023: $52.40 · 2024: $55.24 · 2025: $75.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $75.37 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $60.81 | 2020-2021 | |
| Evofem Biosciences, INC. | $60.02 | 2022-2024 | |
| Becton, Dickinson and Company | $52.63 | 2022-2023 | Bd Onclarity |
| Mayne Pharma Commercial LLC | $28.34 | 2022 | |
| Exeltis, USA INC. | $20.00 | 2023 | Tyblume |
| Intra-Sana Laboratories | $18.51 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Coopersurgical, INC. | $12.80 | 2021 | |
| Avion Pharmaceuticals | $11.42 | 2019 | |
| Lupin INC. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Carmelle Liburd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.